ProQR Therapeutics N.V.
Hedge Funds Holdings
Last updated:
ProQR Therapeutics N.V.‘s stocks are currently a part of 58 hedge funds’ portfolios, which represents 44.59% of the total amount of its stocks outstanding. This makes up a total of 31.76M shares of ProQR Therapeutics N.V.. Compared to the previous quarter, the number fell by -36.74% or -18.44M shares fewer. As for the holding position changes, 27.59% (16) of current hedge fund investors increased the number of shares held, 29.31% (17) of current holders sold a part of the shares held, and 58.62% (34) closed the holdings completely. 18 hedge funds are new holders of ProQR Therapeutics N.V. stock in Q1 2022, it is 31.03% of total holders.
Hedge funds holding ProQR Therapeutics N.V. (Q2 2017 – Q1 2022)
| Q2 2017 | 18 |
|---|---|
| Q3 2017 | 22 |
| Q4 2017 | 26 |
| Q1 2018 | 25 |
| Q2 2018 | 25 |
| Q3 2018 | 35 |
| Q4 2018 | 57 |
| Q1 2019 | 54 |
| Q2 2019 | 55 |
| Q3 2019 | 49 |
| Q4 2019 | 51 |
| Q1 2020 | 44 |
| Q2 2020 | 44 |
| Q3 2020 | 41 |
| Q4 2020 | 46 |
| Q1 2021 | 63 |
| Q2 2021 | 62 |
| Q3 2021 | 65 |
| Q4 2021 | 74 |
| Q1 2022 | 58 |
Hedge funds changes in ProQR Therapeutics N.V. positions (Q2 2017 – Q1 2022)
| Q2 2017 | 3 | 6 | 1 | 3 | 5 |
|---|---|---|---|---|---|
| Q3 2017 | 5 | 9 | 5 | 1 | 2 |
| Q4 2017 | 11 | 4 | 6 | 6 | -1 |
| Q1 2018 | 2 | 8 | 6 | 3 | 6 |
| Q2 2018 | 8 | 4 | 6 | 8 | -1 |
| Q3 2018 | 14 | 8 | 10 | 4 | -1 |
| Q4 2018 | 29 | 10 | 13 | 7 | -2 |
| Q1 2019 | 8 | 17 | 15 | 11 | 3 |
| Q2 2019 | 9 | 14 | 18 | 7 | 7 |
| Q3 2019 | 5 | 16 | 12 | 11 | 5 |
| Q4 2019 | 17 | 21 | 9 | 14 | -10 |
| Q1 2020 | 4 | 14 | 19 | 11 | -4 |
| Q2 2020 | 6 | 17 | 13 | 6 | 2 |
| Q3 2020 | 5 | 11 | 17 | 8 | 0 |
| Q4 2020 | 15 | 7 | 14 | 10 | 0 |
| Q1 2021 | 24 | 23 | 9 | 7 | 0 |
| Q2 2021 | 20 | 15 | 16 | 21 | -10 |
| Q3 2021 | 12 | 27 | 16 | 9 | 1 |
| Q4 2021 | 20 | 24 | 23 | 9 | -2 |
| Q1 2022 | 18 | 16 | 17 | 34 | -27 |
Hedge funds changes in ProQR Therapeutics N.V. stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 1,000 | 0 |
| Q1 2019 | 0 | 27,000 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 22,000 | 15,000 |
| Q1 2020 | 80,000 | 146,000 |
| Q2 2020 | 163,000 | 18,000 |
| Q3 2020 | 8,000 | 3,000 |
| Q4 2020 | 2,000 | 71,000 |
| Q1 2021 | 2,484,000 | 2,059,000 |
| Q2 2021 | 877,000 | 516,000 |
| Q3 2021 | 2,104,000 | 1,278,000 |
| Q4 2021 | 485,000 | 584,000 |
| Q1 2022 | 1,666,000 | 67,000 |